首页 > 最新文献

Public Health Research & Practice最新文献

英文 中文
Engaging Australian men in disease prevention - priorities and opportunities from a national survey. 让澳大利亚男性参与疾病预防——一项全国调查的优先事项和机会。
IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-19 DOI: 10.17061/phrp33342310
Ben Smith, Timothy J Moss, Bernie Marshall, Nicole Halim, Robert Palmer, Simon von Saldern

Objective and importance of the study: In Australia, preventable causes of morbidity and mortality are common among men. The National Men's Health Strategy 2021-2030 highlights the need to successfully engage men in disease prevention; hence, we aimed to examine the prevention priorities, attitudes and information sources reported by Australian men.

Study type: Population survey.

Methods: Men aged 18 years and over were recruited from the nationally representative Life in Australia panel. Participants completed an online survey that measured the prevention issues of greatest concern, attitudes to prevention behaviours and services, and the health information sources considered most useful.

Results: Among 1282 respondents, mental health issues, followed by those pertaining to chronic disease and relationships, were rated of highest concern. Weight management, physical activity, and fruit and vegetable consumption were most often considered as important for personal health. Being 65 years and older and having adequate health literacy were strongly associated with positive attitudes towards prevention practices. More than three-quarters of men rated their doctor as the most useful information source, followed by health websites, internet searching, and their partner.

Conclusions: Psychological and social issues are of high concern to men, and their attitudes toward preventive behaviours and services often do not align with public health recommendations. Understanding the topics of greatest concern to men and their preferred sources of information can inform communication and engagement strategies to improve health-related practices among men.

研究的目的和重要性:在澳大利亚,可预防的发病率和死亡率原因在男性中很常见。《2021-2030年国家男性健康战略》强调了成功让男性参与疾病预防的必要性;因此,我们旨在研究澳大利亚男性报告的预防重点、态度和信息来源。研究类型:人口调查。方法:从具有全国代表性的澳大利亚生活小组中招募18岁及以上的男性。参与者完成了一项在线调查,衡量了人们最关心的预防问题、对预防行为和服务的态度,以及被认为最有用的健康信息来源。结果:在1282名受访者中,心理健康问题被评为最受关注的问题,其次是与慢性病和人际关系有关的问题。体重管理、体育活动、水果和蔬菜消费通常被认为对个人健康很重要。65岁及以上以及具有足够的健康知识与对预防做法的积极态度密切相关。超过四分之三的男性认为他们的医生是最有用的信息来源,其次是健康网站、互联网搜索和他们的伴侣。结论:男性高度关注心理和社会问题,他们对预防行为和服务的态度往往与公共卫生建议不一致。了解男性最关心的话题及其偏好的信息来源,可以为改善男性健康相关做法的沟通和参与策略提供信息。
{"title":"Engaging Australian men in disease prevention - priorities and opportunities from a national survey.","authors":"Ben Smith, Timothy J Moss, Bernie Marshall, Nicole Halim, Robert Palmer, Simon von Saldern","doi":"10.17061/phrp33342310","DOIUrl":"10.17061/phrp33342310","url":null,"abstract":"<p><p>Objective and importance of the study: In Australia, preventable causes of morbidity and mortality are common among men. The National Men's Health Strategy 2021-2030 highlights the need to successfully engage men in disease prevention; hence, we aimed to examine the prevention priorities, attitudes and information sources reported by Australian men.</p><p><strong>Study type: </strong>Population survey.</p><p><strong>Methods: </strong>Men aged 18 years and over were recruited from the nationally representative Life in Australia panel. Participants completed an online survey that measured the prevention issues of greatest concern, attitudes to prevention behaviours and services, and the health information sources considered most useful.</p><p><strong>Results: </strong>Among 1282 respondents, mental health issues, followed by those pertaining to chronic disease and relationships, were rated of highest concern. Weight management, physical activity, and fruit and vegetable consumption were most often considered as important for personal health. Being 65 years and older and having adequate health literacy were strongly associated with positive attitudes towards prevention practices. More than three-quarters of men rated their doctor as the most useful information source, followed by health websites, internet searching, and their partner.</p><p><strong>Conclusions: </strong>Psychological and social issues are of high concern to men, and their attitudes toward preventive behaviours and services often do not align with public health recommendations. Understanding the topics of greatest concern to men and their preferred sources of information can inform communication and engagement strategies to improve health-related practices among men.</p>","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54231548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What role can 'health decision-makers' play in supporting knowledge translation of health and medical research? 卫生决策者 "在支持卫生和医学研究知识转化方面能发挥什么作用?
IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-19 DOI: 10.17061/phrp3422413
Laura Collie, Andrew Milat, Anurag Sharma, Siaw-Teng Liaw, Marianne Gale

CEmbedding research users into the research process can better support its translation into health systems and services. Still, the role of health decision-makers (HDMs) as research partners is poorly understood. HDMs, such as policymakers, administrators, directors or other managers, understand the broader contexts of a health service and have a mandate to facilitate change where appropriate, so they could play an important partnership role in research activities.

将研究用户纳入研究过程可以更好地支持研究成果转化为卫生系统和服务。然而,人们对卫生决策者(HDMs)作为研究伙伴的作用却知之甚少。卫生决策者,如政策制定者、行政人员、主任或其他管理人员,了解更广泛的卫生服务背景,并有责任在适当的时候促进变革,因此他们可以在研究活动中发挥重要的合作伙伴作用。
{"title":"What role can 'health decision-makers' play in supporting knowledge translation of health and medical research?","authors":"Laura Collie, Andrew Milat, Anurag Sharma, Siaw-Teng Liaw, Marianne Gale","doi":"10.17061/phrp3422413","DOIUrl":"10.17061/phrp3422413","url":null,"abstract":"<p><p>CEmbedding research users into the research process can better support its translation into health systems and services. Still, the role of health decision-makers (HDMs) as research partners is poorly understood. HDMs, such as policymakers, administrators, directors or other managers, understand the broader contexts of a health service and have a mandate to facilitate change where appropriate, so they could play an important partnership role in research activities.</p>","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":"34 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global health action delayed: people's health and wellbeing denied. 全球卫生行动延迟:否认人民的健康和福祉。
IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-19 DOI: 10.17061/phrp3422411
Jonathan Abrahams, Fiona Armstrong, Chiedza Malunga, Philipp du Cros
{"title":"Global health action delayed: people's health and wellbeing denied.","authors":"Jonathan Abrahams, Fiona Armstrong, Chiedza Malunga, Philipp du Cros","doi":"10.17061/phrp3422411","DOIUrl":"10.17061/phrp3422411","url":null,"abstract":"","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":"34 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A survey of eyecare affordability among patients seen in collaborative care in Australia and factors contributing to cost barriers. 对澳大利亚合作医疗机构就诊患者的眼科费用承受能力以及造成费用障碍的因素进行调查。
IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-19 DOI: 10.17061/phrp3422415
Rene Cheung, Angelica Ly

Aim: The decline in the real value of rebates from Australia's national public health insurance scheme, Medicare, over the past decade has contributed to increased out-of-pocket costs for eyecare services, which threatens affordability. This study measured eyecare affordability and cost barriers among patients seen in collaborative care.

Methods: We conducted a cross-sectional survey of 252 patients who had attended a collaborative eyecare clinic in the previous year. A modified affordability subscale was used to measure eyecare and general healthcare affordability. Two population scores were calculated: the average percentage of patients experiencing cost barriers (mean of the five item percentages for general healthcare, and optometric and specialist eyecare), and the proportion indicating one or more cost barriers. Factors associated with eyecare and general healthcare affordability were identified using linear regression.

Results: The response rate was 46.8% (n = 118/252). The mean percentage of patients not obtaining services because of cost ranged from 23.4% (standard deviation [SD] 8.8) for general healthcare to 25.5% (SD 6.3) for specialist eyecare. Direct or indirect cost barriers to one or more services were experienced by 45.2% (n = 52/115) of respondents for optometric eyecare and 40.4% (n = 44/109) for specialist eyecare. Services not covered by private health insurance or Medicare (for example, out-of-pocket dental and optical) were ranked the most difficult to afford. Poorer self-rated health (p = 0.004, β = 0.293) and the lack of private hospital health insurance (p = 0.014, β= 0.249) were associated with reduced optometric eyecare affordability. This was also true for specialist eyecare affordability (self-rated health p = 0.002, β = 0.306; private hospital health insurance p = 0.004, β = 0.286). A lack of private hospital health insurance (p = 0.001, β = 0.312), younger age (p < 0.001, β = -0.418) and holding a concession card (p = 0.011, β = 0.272) were all associated with reduced affordability of general healthcare.

Conclusion: A high proportion of patients seen in collaborative care experience cost barriers to accessing eyecare, particularly for services not covered by private health insurance or Medicare. These findings indicate that affordability concerns exist despite significant reductions in the direct cost of services within a collaborative care setting. They also provide insights on the subpopulations most vulnerable to rising eyecare costs.

目的:过去十年来,澳大利亚国家公共医疗保险计划(Medicare)的实际回扣价值下降,导致眼科医疗服务的自付费用增加,威胁到患者的经济承受能力。本研究测量了在合作医疗机构就诊的患者的眼科保健负担能力和费用障碍:方法:我们对 252 名去年曾在眼科合作诊所就诊的患者进行了横断面调查。我们使用修改后的可负担性分量表来测量眼科保健和一般医疗保健的可负担性。我们计算了两个人群得分:遇到费用障碍的患者的平均百分比(普通医疗、验光和专科眼科五个项目百分比的平均值),以及表示有一个或多个费用障碍的比例。采用线性回归法确定了与眼科和普通医疗费用负担能力相关的因素:回复率为 46.8%(n = 118/252)。因费用问题而无法获得服务的患者平均比例从普通医疗服务的 23.4%(标准差 [SD] 8.8)到眼科专科服务的 25.5%(标准差 6.3)不等。45.2%(n=52/115)的受访者在接受验光配镜服务时遇到直接或间接费用障碍,40.4%(n=44/109)的受访者在接受眼科专科服务时遇到直接或间接费用障碍。私人医疗保险或医疗保险不覆盖的服务(例如,自费牙科和眼科)被列为最难负担的服务。自评健康状况较差(p = 0.004,β = 0.293)和没有私人医院医疗保险(p = 0.014,β = 0.249)与视力保健负担能力下降有关。专科眼科保健的可负担性也是如此(自评健康 p = 0.002,β = 0.306;私立医院医疗保险 p = 0.004,β = 0.286)。没有私立医院医疗保险(p = 0.001,β = 0.312)、年龄较小(p < 0.001,β = -0.418)和持有优惠卡(p = 0.011,β = 0.272)都与普通医疗负担能力下降有关:结论:在合作医疗机构就诊的患者中,有很大一部分人在接受眼科治疗时会遇到费用障碍,尤其是对于私人医疗保险或医疗保险不覆盖的服务。这些研究结果表明,尽管合作医疗环境下的直接服务成本大幅降低,但仍存在负担能力方面的问题。这些研究还提供了关于最容易受到眼科费用上涨影响的亚人群的见解。
{"title":"A survey of eyecare affordability among patients seen in collaborative care in Australia and factors contributing to cost barriers.","authors":"Rene Cheung, Angelica Ly","doi":"10.17061/phrp3422415","DOIUrl":"10.17061/phrp3422415","url":null,"abstract":"<p><strong>Aim: </strong>The decline in the real value of rebates from Australia's national public health insurance scheme, Medicare, over the past decade has contributed to increased out-of-pocket costs for eyecare services, which threatens affordability. This study measured eyecare affordability and cost barriers among patients seen in collaborative care.</p><p><strong>Methods: </strong>We conducted a cross-sectional survey of 252 patients who had attended a collaborative eyecare clinic in the previous year. A modified affordability subscale was used to measure eyecare and general healthcare affordability. Two population scores were calculated: the average percentage of patients experiencing cost barriers (mean of the five item percentages for general healthcare, and optometric and specialist eyecare), and the proportion indicating one or more cost barriers. Factors associated with eyecare and general healthcare affordability were identified using linear regression.</p><p><strong>Results: </strong>The response rate was 46.8% (n = 118/252). The mean percentage of patients not obtaining services because of cost ranged from 23.4% (standard deviation [SD] 8.8) for general healthcare to 25.5% (SD 6.3) for specialist eyecare. Direct or indirect cost barriers to one or more services were experienced by 45.2% (n = 52/115) of respondents for optometric eyecare and 40.4% (n = 44/109) for specialist eyecare. Services not covered by private health insurance or Medicare (for example, out-of-pocket dental and optical) were ranked the most difficult to afford. Poorer self-rated health (p = 0.004, β = 0.293) and the lack of private hospital health insurance (p = 0.014, β= 0.249) were associated with reduced optometric eyecare affordability. This was also true for specialist eyecare affordability (self-rated health p = 0.002, β = 0.306; private hospital health insurance p = 0.004, β = 0.286). A lack of private hospital health insurance (p = 0.001, β = 0.312), younger age (p < 0.001, β = -0.418) and holding a concession card (p = 0.011, β = 0.272) were all associated with reduced affordability of general healthcare.</p><p><strong>Conclusion: </strong>A high proportion of patients seen in collaborative care experience cost barriers to accessing eyecare, particularly for services not covered by private health insurance or Medicare. These findings indicate that affordability concerns exist despite significant reductions in the direct cost of services within a collaborative care setting. They also provide insights on the subpopulations most vulnerable to rising eyecare costs.</p>","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":"34 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving access to catch-up immunisations for humanitarian arrivals: a qualitative study. 改善人道主义抵达者获得补种免疫接种的机会:一项定性研究。
IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-19 DOI: 10.17061/phrp3422417
Shamila Ginige, Holly Seale, Kate Alexander
{"title":"Improving access to catch-up immunisations for humanitarian arrivals: a qualitative study.","authors":"Shamila Ginige, Holly Seale, Kate Alexander","doi":"10.17061/phrp3422417","DOIUrl":"10.17061/phrp3422417","url":null,"abstract":"","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":"34 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in systemic cancer therapy in Australia during the Delta and Omicron waves of the COVID-19 pandemic (2021-2022): a controlled interrupted time series analysis. COVID-19 大流行的德尔塔波和奥米克隆波(2021-2022 年)期间澳大利亚系统性癌症治疗的变化:受控间断时间序列分析。
IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-19 DOI: 10.17061/phrp34012402
Forrest C Koch, Monica Tang, Ramesh Walpola, Maria Aslam, Sallie-Anne Pearson, Benjamin Daniels

Objectives: Australian lockdowns in response to the initial coronavirus disease 2019 (COVID-19) outbreak in 2020 were associated with small and transient changes in the use of systemic cancer therapy. We aimed to investigate the impacts of the longer and more restrictive lockdowns in the Australian states of New South Wales (NSW) and Victoria during both the Delta subvariant lockdowns in mid-2021 and the Omicron subvariant outbreak in late 2021/early 2022.

Study type: Population-based, controlled interrupted time series analysis.

Methods: We conducted a national observational study using de-identified records of government-subsidised cancer medicines dispensed to a random 10% sample of Australians between July 2018 and July 2022. We used controlled interrupted time series analysis to investigate changes in the dispensing, initiation and discontinuation of all cancer medicines dispensed to residents of NSW and Victoria, using the rest of Australia as a control series. We used quasi-Poisson regression to model weekly counts and estimate incidence rate ratios (IRRs) for the effect of (each) the Delta phase lockdown and the Omicron outbreak on our systemic cancer therapy outcomes.

Results: Between July 2018 and July 2022, cancer medicines were dispensed 592 141 times to 33 198 people in NSW and Victoria. Overall, there were no changes to the rates of dispensing, initiation or discontinuation of antineoplastics during the Delta phase lockdowns. In both states during the Omicron outbreak, there were significant decreases in the dispensing of antineoplastics (NSW IRR 0.89; 95% confidence interval [CI] 0.84, 0.93. Victoria IRR 0.92; 95% CI 0.88, 0.96) and in the initiation of endocrine therapy (NSW IRR 0.85; 95% CI 0.74, 0.99. Victoria IRR 0.78; 95% CI 0.65, 0.94), and no changes in the discontinuation of any systemic cancer therapy.

Conclusions: The 2021 lockdowns and 2021/2022 Omicron outbreaks in NSW and Victoria had significant impacts on the dispensing, initiation and discontinuation of systemic cancer therapies, however, the overall effects were minimal. The impacts of lockdowns were less significant than the Omicron outbreaks, suggesting COVID-19 infection, health system capacity, and patient and community concerns were important factors for treatment changes.

目的:澳大利亚在 2020 年为应对 2019 年冠状病毒病(COVID-19)的首次爆发而实施的封锁措施与系统性癌症疗法的使用方面发生的微小而短暂的变化有关。我们旨在调查澳大利亚新南威尔士州(NSW)和维多利亚州在 2021 年年中德尔塔亚变体锁定和 2021 年末/2022 年初奥米克隆亚变体爆发期间更长时间和更严格锁定的影响:研究类型:基于人群的对照中断时间序列分析:我们利用 2018 年 7 月至 2022 年 7 月期间向随机 10% 的澳大利亚人样本发放的政府补贴癌症药物的去标识化记录,开展了一项全国性观察研究。我们采用受控间断时间序列分析法,以澳大利亚其他地区为对照序列,调查了新南威尔士州和维多利亚州居民所有抗癌药物的配发、启动和停用情况的变化。我们使用准泊松回归法建立周计数模型,并估算出德尔塔阶段封锁和奥米克龙爆发对全身性癌症治疗结果影响的发病率比(IRRs):2018 年 7 月至 2022 年 7 月期间,新南威尔士州和维多利亚州共向 33 198 人配发了 592 141 次抗癌药物。总体而言,在德尔塔阶段封锁期间,抗肿瘤药物的配发率、启动率或停药率均未发生变化。在 Omicron 疫情爆发期间,新南威尔士州和维多利亚州的抗肿瘤药物配发率显著下降(新南威尔士州 IRR 0.89;95% 置信区间 [CI] 0.84,0.93。维多利亚州 IRR 0.92;95% CI 0.88,0.96)和内分泌治疗的启动(新南威尔士州 IRR 0.85;95% CI 0.74,0.99;维多利亚州 IRR 0.78;95% CI 0.65,0.94),而停止任何系统性癌症治疗的情况没有变化:新南威尔士州和维多利亚州 2021 年的停药和 2021/2022 年的 Omicron 疫情对系统性癌症疗法的配药、启动和停药产生了重大影响,但总体影响甚微。与 Omicron 疫情相比,封锁的影响较小,这表明 COVID-19 感染、医疗系统的能力以及患者和社区的担忧是导致治疗改变的重要因素。
{"title":"Changes in systemic cancer therapy in Australia during the Delta and Omicron waves of the COVID-19 pandemic (2021-2022): a controlled interrupted time series analysis.","authors":"Forrest C Koch, Monica Tang, Ramesh Walpola, Maria Aslam, Sallie-Anne Pearson, Benjamin Daniels","doi":"10.17061/phrp34012402","DOIUrl":"10.17061/phrp34012402","url":null,"abstract":"<p><strong>Objectives: </strong>Australian lockdowns in response to the initial coronavirus disease 2019 (COVID-19) outbreak in 2020 were associated with small and transient changes in the use of systemic cancer therapy. We aimed to investigate the impacts of the longer and more restrictive lockdowns in the Australian states of New South Wales (NSW) and Victoria during both the Delta subvariant lockdowns in mid-2021 and the Omicron subvariant outbreak in late 2021/early 2022.</p><p><strong>Study type: </strong>Population-based, controlled interrupted time series analysis.</p><p><strong>Methods: </strong>We conducted a national observational study using de-identified records of government-subsidised cancer medicines dispensed to a random 10% sample of Australians between July 2018 and July 2022. We used controlled interrupted time series analysis to investigate changes in the dispensing, initiation and discontinuation of all cancer medicines dispensed to residents of NSW and Victoria, using the rest of Australia as a control series. We used quasi-Poisson regression to model weekly counts and estimate incidence rate ratios (IRRs) for the effect of (each) the Delta phase lockdown and the Omicron outbreak on our systemic cancer therapy outcomes.</p><p><strong>Results: </strong>Between July 2018 and July 2022, cancer medicines were dispensed 592 141 times to 33 198 people in NSW and Victoria. Overall, there were no changes to the rates of dispensing, initiation or discontinuation of antineoplastics during the Delta phase lockdowns. In both states during the Omicron outbreak, there were significant decreases in the dispensing of antineoplastics (NSW IRR 0.89; 95% confidence interval [CI] 0.84, 0.93. Victoria IRR 0.92; 95% CI 0.88, 0.96) and in the initiation of endocrine therapy (NSW IRR 0.85; 95% CI 0.74, 0.99. Victoria IRR 0.78; 95% CI 0.65, 0.94), and no changes in the discontinuation of any systemic cancer therapy.</p><p><strong>Conclusions: </strong>The 2021 lockdowns and 2021/2022 Omicron outbreaks in NSW and Victoria had significant impacts on the dispensing, initiation and discontinuation of systemic cancer therapies, however, the overall effects were minimal. The impacts of lockdowns were less significant than the Omicron outbreaks, suggesting COVID-19 infection, health system capacity, and patient and community concerns were important factors for treatment changes.</p>","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139900681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skin checks for potential skin cancers in general practice in Victoria, Australia: the upfront and downstream patterns and costs. 在澳大利亚维多利亚州的一般实践中,潜在皮肤癌的皮肤检查:前期和后期模式和成本。
IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-01 DOI: 10.17061/phrp34122406
David E Goldsbury, Damien McCarthy, Caroline G Watts, Chi So, Olivia Wawryk, Chris Kearney, Gillian Reyes-Marcelino, Kirstie McLoughlin, Jon Emery, Anne E Cust

Objectives: To describe patterns of skin checks for potential skin cancers in general practice and subsequent skin-related healthcare, and the associated costs.

Study type: Retrospective longitudinal health record linkage.

Methods: Patient encounters between 2010 and 2017 were extracted from clinical information systems at 73 general practice sites in Victoria, Australia, including Medicare billing information, from the MedicineInsight primary care dataset. The main outcomes were skin checks, skin-related healthcare up to 3 months after the skin check, and health system costs.

Results: There were 59 046 skin check encounters (0.7% of all general practice encounters) identified for 40 014 people with a median age of 52 years (interquartile range 36-67). Of these people, 26% had multiple skin checks. Of the subsequent skin checks, 28% were within 3 months of the initial skin check and 15% were after > 2 years. There was subsequent skin-related healthcare ≤ 3 months after 20% of all skin checks: 8% had a skin biopsy, 11% had a skin excision (of which 2% indicated a melanoma diagnosis, 29% keratinocyte carcinoma and 68% benign or other skin lesion), 2% had skin-related medicine prescribed and 5% had other skin-related treatment such as cryotherapy (not mutually exclusive). Ninety per cent of skin checks were billed as general practitioner (GP) consultations, including 65% as GP consultations of < 20 minutes although the proportion of longer consultations increased over time. The mean 3-month skin-related general practice health system costs for people without and with subsequent skin-related healthcare were A$58 and A$240, respectively, and up to a mean of A$595 for those having a melanoma excised.

Conclusions: Skin checks for potential skin cancers occur frequently in Australian general practice and accumulate substantial health system costs, with one in five skin checks resulting in subsequent treatment. This study adds to scarce real-world skin check and cost data in Australia.

目的描述全科医生和随后的皮肤相关保健中潜在皮肤癌的皮肤检查模式,以及相关费用。研究类型回顾性纵向健康记录关联。方法从澳大利亚维多利亚州73个全科诊所的临床信息系统中提取2010年至2017年的患者就诊情况,包括来自MedicineInsight初级保健数据集的医疗保险计费信息。主要结果为皮肤检查、皮肤检查后3个月的皮肤相关保健和卫生系统费用。结果40 014例患者中有59 046例皮肤检查(占全科就诊的0.7%),中位年龄为52岁(四分位数范围为36-67岁)。在这些人中,26%的人进行了多次皮肤检查。在随后的皮肤检查中,28%是在首次皮肤检查的3个月内进行的,15%是在2年后进行的。在所有皮肤检查中,有20%的患者在3个月内接受了皮肤相关的医疗保健:8%进行了皮肤活检,11%进行了皮肤切除术(其中2%诊断为黑色素瘤,29%为角化细胞癌,68%为良性或其他皮肤病变),2%开具了皮肤相关药物处方,5%接受了其他皮肤相关治疗,如冷冻疗法(不相互排斥)。90%的皮肤检查被称为全科医生(GP)咨询,其中65%的人被称为全科医生咨询。结论:针对潜在皮肤癌的皮肤检查在澳大利亚的全科医生中经常发生,并积累了大量的卫生系统成本,五分之一的皮肤检查导致后续治疗。这项研究补充了澳大利亚稀缺的真实皮肤检查和成本数据。
{"title":"Skin checks for potential skin cancers in general practice in Victoria, Australia: the upfront and downstream patterns and costs.","authors":"David E Goldsbury, Damien McCarthy, Caroline G Watts, Chi So, Olivia Wawryk, Chris Kearney, Gillian Reyes-Marcelino, Kirstie McLoughlin, Jon Emery, Anne E Cust","doi":"10.17061/phrp34122406","DOIUrl":"10.17061/phrp34122406","url":null,"abstract":"<p><strong>Objectives: </strong>To describe patterns of skin checks for potential skin cancers in general practice and subsequent skin-related healthcare, and the associated costs.</p><p><strong>Study type: </strong>Retrospective longitudinal health record linkage.</p><p><strong>Methods: </strong>Patient encounters between 2010 and 2017 were extracted from clinical information systems at 73 general practice sites in Victoria, Australia, including Medicare billing information, from the MedicineInsight primary care dataset. The main outcomes were skin checks, skin-related healthcare up to 3 months after the skin check, and health system costs.</p><p><strong>Results: </strong>There were 59 046 skin check encounters (0.7% of all general practice encounters) identified for 40 014 people with a median age of 52 years (interquartile range 36-67). Of these people, 26% had multiple skin checks. Of the subsequent skin checks, 28% were within 3 months of the initial skin check and 15% were after > 2 years. There was subsequent skin-related healthcare ≤ 3 months after 20% of all skin checks: 8% had a skin biopsy, 11% had a skin excision (of which 2% indicated a melanoma diagnosis, 29% keratinocyte carcinoma and 68% benign or other skin lesion), 2% had skin-related medicine prescribed and 5% had other skin-related treatment such as cryotherapy (not mutually exclusive). Ninety per cent of skin checks were billed as general practitioner (GP) consultations, including 65% as GP consultations of < 20 minutes although the proportion of longer consultations increased over time. The mean 3-month skin-related general practice health system costs for people without and with subsequent skin-related healthcare were A$58 and A$240, respectively, and up to a mean of A$595 for those having a melanoma excised.</p><p><strong>Conclusions: </strong>Skin checks for potential skin cancers occur frequently in Australian general practice and accumulate substantial health system costs, with one in five skin checks resulting in subsequent treatment. This study adds to scarce real-world skin check and cost data in Australia.</p>","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":"35 ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144183214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiences of research-policy engagement in policy-making processes. 研究-政策参与决策过程的经验。
IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-04-04 DOI: 10.17061/phrp33232308
Carmel Williams, Tahna Pettman, Ian Goodwin-Smith, Yonatal M Tefera, Somayya Hanifie, Katherine L Baldock

Objectives and importance of study: For public policy to respond effectively to social, economic, and health challenges, there is an urgent need for research-policy collaboration to advance evidence-informed policy. Many organisations seek to promote these engagement activities, but little is known about how this is experienced by researchers and policy actors. This study aimed to understand how policy actors and researchers in Australia experience collaboration and the impediments and enablers they encounter. Study type and methods: An online survey was developed, and using convenience sampling, self-identified Australian policy actors and researchers were invited to participate. Results: In total, 170 responses were analysed, comprising 58% policy actors and 42% researchers. Respondents reported the primary purpose for collaboration was evidence-informed policy making. Policy actors reported that the most common barrier to collaboration with academics was 'budget constraints' while academics reported 'budget, 'political risk' and 'structural barriers'. Reported enablers were 'leadership' and 'connections'. Conclusions: Our findings build upon existing evidence that highlights the importance of collaboration for facilitating evidence-informed policy. Structural deficits in both policy agencies and research funding systems and environments continue to present challenges to policy-research partnerships. Future initiatives could use these findings to implement preferred collaboration methods, alongside rigorous evaluation, to explore 'what works' in promoting engagement for evidence-informed policy.

研究的目标和重要性:为了使公共政策有效应对社会、经济和健康方面的挑战,迫切需要开展研究与政策合作,以推进有实证依据的政策。许多组织都在努力促进这些参与活动,但研究人员和政策制定者对此却知之甚少。本研究旨在了解澳大利亚的政策参与者和研究人员是如何体验合作的,以及他们遇到的障碍和推动因素。研究类型和方法:本研究开发了一项在线调查,并采用方便抽样的方法,邀请自我认同的澳大利亚政策参与者和研究人员参与调查。结果:共分析了 170 份回复,其中 58% 为政策参与者,42% 为研究人员。受访者表示,合作的主要目的是制定有依据的政策。政策制定者报告称,与学术界合作最常见的障碍是 "预算限制",而学术界则报告了 "预算、政治风险 "和 "结构性障碍"。所报告的促进因素是 "领导力 "和 "联系"。结论:我们的研究结果以现有证据为基础,强调了合作对于促进循证政策的重要性。政策机构和研究资助体系及环境中的结构性缺陷继续给政策研究合作带来挑战。未来的倡议可以利用这些发现来实施首选的合作方法,同时进行严格的评估,以探索在促进循证政策参与方面 "什么是有效的"。
{"title":"Experiences of research-policy engagement in policy-making processes.","authors":"Carmel Williams, Tahna Pettman, Ian Goodwin-Smith, Yonatal M Tefera, Somayya Hanifie, Katherine L Baldock","doi":"10.17061/phrp33232308","DOIUrl":"10.17061/phrp33232308","url":null,"abstract":"<p><p>Objectives and importance of study: For public policy to respond effectively to social, economic, and health challenges, there is an urgent need for research-policy collaboration to advance evidence-informed policy. Many organisations seek to promote these engagement activities, but little is known about how this is experienced by researchers and policy actors. This study aimed to understand how policy actors and researchers in Australia experience collaboration and the impediments and enablers they encounter. Study type and methods: An online survey was developed, and using convenience sampling, self-identified Australian policy actors and researchers were invited to participate. Results: In total, 170 responses were analysed, comprising 58% policy actors and 42% researchers. Respondents reported the primary purpose for collaboration was evidence-informed policy making. Policy actors reported that the most common barrier to collaboration with academics was 'budget constraints' while academics reported 'budget, 'political risk' and 'structural barriers'. Reported enablers were 'leadership' and 'connections'. Conclusions: Our findings build upon existing evidence that highlights the importance of collaboration for facilitating evidence-informed policy. Structural deficits in both policy agencies and research funding systems and environments continue to present challenges to policy-research partnerships. Future initiatives could use these findings to implement preferred collaboration methods, alongside rigorous evaluation, to explore 'what works' in promoting engagement for evidence-informed policy.</p>","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9957870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of targeted SMS messaging to encourage COVID-19 oral antiviral uptake in South West Victoria. 在西南维多利亚州使用定向短信鼓励新冠肺炎口服抗病毒药物。
IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-04-04 DOI: 10.17061/phrp33342309
Naomi E Clarke, Jessica O'Keeffe, Arvind Yerramilli, Caroline Bartolo, Nomvuyo Mothobi, Michael Muleme, Bridgette J McNamara, Daniel P O'Brien, Eugene Athan, Akhtar Hussain

Objectives: During winter 2022, as part of a multifaceted approach to optimise oral antiviral uptake in the Barwon South West region in Victoria, Australia, the Barwon South West Public Health Unit (BSWPHU) implemented an innovative, targeted SMS messaging program that encouraged people with coronavirus disease 2019 (COVID-19) to be assessed for antiviral treatment. In this study, we investigated patterns of antiviral uptake, identified barriers and facilitators to accessing antivirals, and examined the potential impact of targeted SMS messaging on oral antiviral uptake.

Methods: We conducted a cross-sectional study of notified COVID-19 cases aged 50 years and older, and Aboriginal and Torres Strait Islander people aged 30-49 years, in the BSWPHU catchment area over a 6-week period commencing 21 July 2022. We analysed survey data using descriptive statistics and generalised linear models.

Results: Of the 3829 survey respondents, 36.7% (95% confidence interval (CI) 35.2, 38.2) reported being prescribed oral antivirals, with 75.4% (95% CI 72.8, 77.9) of these aged ≥70. Antiviral prescriptions increased significantly over the 6-week survey period. Most prescriptions (87.5%; 95% CI 85.7, 89.2) were provided by the respondents' usual general practitioners (GPs). Barriers to receiving antivirals included respondents being unable to get a medical appointment in time (3.7%; 95% CI 3.1, 4.2), testing too late in their illness (2.3%; 95% CI 1.8, 2.8) and being unable to access medications in time after receiving a prescription (0.2%; 95% CI 0.1, 0.6). Facilitators to receiving antivirals included respondents first hearing about antivirals from a trusted source such as a family member, friend or usual doctor. Nearly one in eight people who were prescribed antivirals reported first hearing about them from the SMS message sent by BSWPHU.

Conclusions: Oral antiviral treatment uptake in south-west Victoria in July-August 2022 was high among survey respondents and increased over time. GPs were the key prescribers in the community. Targeted SMS messaging to COVID-19 cases is a simple, low-cost intervention that potentially increases antiviral uptake.

目标:2022年冬季,作为澳大利亚维多利亚州巴温西南地区优化口服抗病毒药物摄入的多方面方法的一部分,巴温西南公共卫生部门(BSWPHU)实施了一项创新的、有针对性的短信计划,鼓励2019冠状病毒病(新冠肺炎)患者接受抗病毒治疗评估。在这项研究中,我们调查了抗病毒药物的摄取模式,确定了获得抗病毒药物的障碍和促进因素,并研究了定向短信对口服抗病毒药物摄取的潜在影响。方法:我们从2022年7月21日开始,在为期6周的时间内,对BSWPHU流域50岁及以上的新冠肺炎确诊病例以及30-49岁的原住民和托雷斯海峡岛民进行了横断面研究。我们使用描述性统计和广义线性模型分析了调查数据。结果:在3829名调查对象中,36.7%(95%置信区间(CI)35.2,38.2)的人报告服用了口服抗病毒药物,其中75.4%(95%CI 72.8,77.9)的人年龄≥70岁。在为期6周的调查期间,抗病毒药物处方显著增加。大多数处方(87.5%;95%CI 85.7,89.2)由受访者的普通全科医生提供。接受抗病毒药物治疗的障碍包括受访者无法及时获得医疗预约(3.7%;95%置信区间3.1、4.2),在疾病中检测太迟(2.3%;95%CI 1.8,2.8),以及在收到处方后无法及时获得药物(0.2%;95%CI 0.1,0.6)。接受抗病毒药物的促进者包括首次从可靠来源(如家人、朋友或普通医生)听说抗病毒药物的受访者。近八分之一的服用抗病毒药物的人报告说,他们是从BSWPHU发送的短信中第一次听说抗病毒药物的。结论:2022年7月至8月,维多利亚州西南部的口服抗病毒治疗接受率在调查对象中较高,并随着时间的推移而增加。全科医生是社区的主要处方医生。针对新冠肺炎病例的短信是一种简单、低成本的干预措施,可能会增加抗病毒药物的摄入。
{"title":"Use of targeted SMS messaging to encourage COVID-19 oral antiviral uptake in South West Victoria.","authors":"Naomi E Clarke, Jessica O'Keeffe, Arvind Yerramilli, Caroline Bartolo, Nomvuyo Mothobi, Michael Muleme, Bridgette J McNamara, Daniel P O'Brien, Eugene Athan, Akhtar Hussain","doi":"10.17061/phrp33342309","DOIUrl":"10.17061/phrp33342309","url":null,"abstract":"<p><strong>Objectives: </strong>During winter 2022, as part of a multifaceted approach to optimise oral antiviral uptake in the Barwon South West region in Victoria, Australia, the Barwon South West Public Health Unit (BSWPHU) implemented an innovative, targeted SMS messaging program that encouraged people with coronavirus disease 2019 (COVID-19) to be assessed for antiviral treatment. In this study, we investigated patterns of antiviral uptake, identified barriers and facilitators to accessing antivirals, and examined the potential impact of targeted SMS messaging on oral antiviral uptake.</p><p><strong>Methods: </strong>We conducted a cross-sectional study of notified COVID-19 cases aged 50 years and older, and Aboriginal and Torres Strait Islander people aged 30-49 years, in the BSWPHU catchment area over a 6-week period commencing 21 July 2022. We analysed survey data using descriptive statistics and generalised linear models.</p><p><strong>Results: </strong>Of the 3829 survey respondents, 36.7% (95% confidence interval (CI) 35.2, 38.2) reported being prescribed oral antivirals, with 75.4% (95% CI 72.8, 77.9) of these aged ≥70. Antiviral prescriptions increased significantly over the 6-week survey period. Most prescriptions (87.5%; 95% CI 85.7, 89.2) were provided by the respondents' usual general practitioners (GPs). Barriers to receiving antivirals included respondents being unable to get a medical appointment in time (3.7%; 95% CI 3.1, 4.2), testing too late in their illness (2.3%; 95% CI 1.8, 2.8) and being unable to access medications in time after receiving a prescription (0.2%; 95% CI 0.1, 0.6). Facilitators to receiving antivirals included respondents first hearing about antivirals from a trusted source such as a family member, friend or usual doctor. Nearly one in eight people who were prescribed antivirals reported first hearing about them from the SMS message sent by BSWPHU.</p><p><strong>Conclusions: </strong>Oral antiviral treatment uptake in south-west Victoria in July-August 2022 was high among survey respondents and increased over time. GPs were the key prescribers in the community. Targeted SMS messaging to COVID-19 cases is a simple, low-cost intervention that potentially increases antiviral uptake.</p>","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41158694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Building prevention research science communication and knowledge translation capacity through multidisciplinary collaboration. 通过多学科合作提高预防研究科学传播和知识转化能力。
IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-04-04 DOI: 10.17061/phrp3412409
Shaan S Naughton, Konsita Kuswara, Ainsley E Burgess, Helen C Dinmore, Cindy Jones, Karen Metcalfe, Heidi Turon, Helen Signy

Objective: To document the outcomes of a dedicated Science Communication Community of Practice (CoP) for increasing prevention-focused knowledge translation (KT) and evidence uptake. Type of program: Shared priorities and a united vision to communicate the value of prevention research led to the formation of a dedicated Science Communication CoP within an Australian public health prevention-focused research collaboration. Members of the CoP included science communication experts and early- and mid-career researchers (EMCRs) with KT-focused roles.

Methods: The CoP met monthly, with semi-structured meetings led by an experienced science communication professional. A priority of the CoP was to develop resources that could help members and external parties to communicate their findings, especially EMCRs and those working on low-resourced projects. Insights from CoP members were synthesised to document if, and how, the CoP increased communication and KT capacity.

Results: CoP members found that participatory dialogue - dialogue that involves sharing perspectives and listening to others in order to develop a shared understanding - helped promote a greater understanding of science communication techniques and led to KT being embedded within projects. The CoP itself resulted in shared narratives and communication outputs that could not have been produced by individual members, primarily due to a lack of dedicated resourcing. Members found that engaging in the CoP increased their use of a range of science communication skills, tactics, and methods (e.g., targeted messaging for policy and practice, use of media and social media, and event management to engage audiences and build trust).

Lessons learnt: The CoP helped build a greater working knowledge of science communication among its members, leading to increased KT activities. Within an environment of low resourcing for science communication, bringing researchers together with science communication experts can help promote the communication of synthesised evidence and unified messaging on 'what works for prevention'.

目的:记录一个专门的科学传播实践社区(CoP)的成果,以增加以预防为重点的知识转化(KT)和证据吸收。计划类型:在澳大利亚一个以公共卫生预防为重点的研究合作项目中,由于在传播预防研究价值方面有着共同的优先事项和一致的愿景,因此成立了一个专门的科学传播实践社区(CoP)。合作小组成员包括科学传播专家和以 KT 为重点的中早期研究人员 (EMCR):方法:合作小组每月召开一次会议,由一名经验丰富的科学传播专家主持半结构化会议。该委员会的首要任务是开发资源,帮助委员会成员和外部人员,尤其是 EMCR 和那些从事资源匮乏项目的人员,传播他们的研究成果。CoP 成员的意见得到了综合,以记录 CoP 是否以及如何提高了传播和 KT 能力:结果:CoP 成员发现,参与式对话(对话包括分享观点和倾听他人意见,以形成共同的理解)有助于促进对科学传播技术的进一步理解,并将知识共享纳入项目。主要由于缺乏专门资源,合作伙 伴关系本身产生了单个成员无法产生的共同叙述和传播成果。成员们发现,参与合作伙 伴关系提高了他们对一系列科学传播技能、策略和方法的使用(例如,为政策和实践提供有 针对性的信息、使用媒体和社交媒体以及活动管理,以吸引受众并建立信任):经验与教训:科学政策委员会帮助其成员提高了对科学传播的工作认识,从而增加了科 学传播活动。在科学传播资源较少的情况下,将研究人员与科学传播专家聚集在一起,有助于促进综合证据的传播和关于 "什么对预防有效 "的统一信息的传播。
{"title":"Building prevention research science communication and knowledge translation capacity through multidisciplinary collaboration.","authors":"Shaan S Naughton, Konsita Kuswara, Ainsley E Burgess, Helen C Dinmore, Cindy Jones, Karen Metcalfe, Heidi Turon, Helen Signy","doi":"10.17061/phrp3412409","DOIUrl":"10.17061/phrp3412409","url":null,"abstract":"<p><strong>Objective: </strong>To document the outcomes of a dedicated Science Communication Community of Practice (CoP) for increasing prevention-focused knowledge translation (KT) and evidence uptake. Type of program: Shared priorities and a united vision to communicate the value of prevention research led to the formation of a dedicated Science Communication CoP within an Australian public health prevention-focused research collaboration. Members of the CoP included science communication experts and early- and mid-career researchers (EMCRs) with KT-focused roles.</p><p><strong>Methods: </strong>The CoP met monthly, with semi-structured meetings led by an experienced science communication professional. A priority of the CoP was to develop resources that could help members and external parties to communicate their findings, especially EMCRs and those working on low-resourced projects. Insights from CoP members were synthesised to document if, and how, the CoP increased communication and KT capacity.</p><p><strong>Results: </strong>CoP members found that participatory dialogue - dialogue that involves sharing perspectives and listening to others in order to develop a shared understanding - helped promote a greater understanding of science communication techniques and led to KT being embedded within projects. The CoP itself resulted in shared narratives and communication outputs that could not have been produced by individual members, primarily due to a lack of dedicated resourcing. Members found that engaging in the CoP increased their use of a range of science communication skills, tactics, and methods (e.g., targeted messaging for policy and practice, use of media and social media, and event management to engage audiences and build trust).</p><p><strong>Lessons learnt: </strong>The CoP helped build a greater working knowledge of science communication among its members, leading to increased KT activities. Within an environment of low resourcing for science communication, bringing researchers together with science communication experts can help promote the communication of synthesised evidence and unified messaging on 'what works for prevention'.</p>","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":"34 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140865216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Public Health Research & Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1